Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial

被引：0
|
作者：
M. R. McClung
E. M. Lewiecki
M. L. Geller
M. A. Bolognese
M. Peacock
R. L. Weinstein
B. Ding
E. Rockabrand
R. B. Wagman
P. D. Miller
机构：
[1] Oregon Osteoporosis Center,
[2] New Mexico Clinical Research & Osteoporosis Center,undefined
[3] Amgen Inc.,undefined
[4] Bethesda Health Research Center,undefined
[5] Indiana University School of Medicine,undefined
[6] Diablo Clinical Research,undefined
[7] Inc.,undefined
[8] Colorado Center for Bone Research,undefined
来源：
Osteoporosis International | 2013年 / 24卷
关键词：
Bone mineral density; Bone turnover markers; Denosumab; Osteoporosis; RANK ligand;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：227 / 235
页数：8
相关论文
共 50 条
  • [1] Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
    McClung, M. R.
    Lewiecki, E. M.
    Geller, M. L.
    Bolognese, M. A.
    Peacock, M.
    Weinstein, R. L.
    Ding, B.
    Rockabrand, E.
    Wagman, R. B.
    Miller, P. D.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (01) : 227 - 235
  • [2] Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial
    Miller, Paul D.
    Wagman, Rachel B.
    Peacock, Munro
    Lewiecki, E. Michael
    Bolognese, Michael A.
    Weinstein, Richard L.
    Ding, Beiying
    Martin, Javier San
    McClung, Michael R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (02): : 394 - 402
  • [3] DENOSUMAB CONTINUES TO AFFECT BONE MINERAL DENSITY AND BIOCHEMICAL MARKERS OF BONE TURNOVER FOR UP TO 8 YEARS: RESULTS OF A PHASE 2 EXTENSION TRIAL
    McClung, M. R.
    Lewiecki, E. M.
    Bolognese, M. A.
    Peacock, M.
    Weinstein, R. L.
    Ding, B.
    Geller, M. L.
    Grauer, A.
    Ho, P. R.
    Wagman, R. B.
    Miller, P. D.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S74 - S76
  • [4] Effect of Denosumab on bone mineral density and markers of bone turnover
    Sanchez, A.
    Brun, L. R.
    Salerni, H.
    Costanzo, P.
    Zanchetta, M. B.
    Farias, V.
    Maffei, L.
    Premrou, V.
    Larroude, M. S.
    Sarli, M. A.
    Rey, P.
    Brance, M. L.
    Pavlove, M. M.
    Karlsbrum, S.
    BONE, 2016, 89 : 66 - 67
  • [5] Effects of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover Over 8 Years
    McClung, Michael R.
    Lewiecki, E. Michael
    Bolognese, Michael A.
    Peacock, Munro
    Weinstein, Richard L.
    Ding, Beiying
    Geller, Michelle L.
    Grauer, Andreas
    Wagman, Rachel B.
    Miller, Paul D.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S433 - S433
  • [6] Effect of denosumab on bone mineral density and bone turnover markers: 48-month results
    Miller, P.
    Bolognese, M.
    Lewiecki, E. M.
    McClung, M.
    Ding, B.
    Liu, Y.
    Martin, J. San
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S58 - S58
  • [7] Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
    Sanchez, A.
    Brun, L. R.
    Salerni, H.
    Costanzo, P. R.
    Gonzalez, D.
    Bagur, A.
    Oliveri, B.
    Zanchetta, M. B.
    Farias, V.
    Maffei, L.
    Premrou, V.
    Mansur, J. L.
    Larroude, M. S.
    Sarli, M. A.
    Rey, P.
    Ulla, M. R.
    Pavlove, M. M.
    Karlsbrum, S.
    Brance, M. L.
    JOURNAL OF OSTEOPOROSIS, 2016, 2016
  • [8] EFFECT OF ODANACATIB ON BONE DENSITY AND BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: YEAR 4 RESULTS
    Eisman, J. A.
    Binkley, N.
    Bone, H.
    Hosking, D.
    Langdahl, B.
    Reid, I.
    Resch, H.
    Rodriguez Portales, J.
    De Tilleghem, C. Le Bailly
    Hustad, C.
    DaSilva, C.
    Santora, A.
    Denker, A.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S526 - S526
  • [9] Effect of Odanacatib on Bone Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mineral Density: Year 4 Results
    Leung, Albert
    Petrovic, Romana
    DaSilva, Carolyn
    Rosenberg, Elizabeth
    Santora, Arthur
    Lombardi, Antonio
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1179 - 1180
  • [10] Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women - The fracture intervention trial
    Keegan, THM
    Schwartz, AV
    Bauer, DC
    Sellmeyer, DE
    Kelsey, JL
    DIABETES CARE, 2004, 27 (07) : 1547 - 1553
12345